Faculty

Back to Index
Pisit Pitukcheewanont, MD
Professor of Clinical Pediatrics
Pediatrics
CHL Mail Stop 61 Off Campus Los Angeles
+1 323 361 2500

Overview

Pisit Pitukcheewanont, MD, also known as Dr. Duke, is an associate professor of Clinical Pediatrics and Clinical Director of the Pediatric Bone Program at Center of Endocrinology, Diabetes and Metabolism at Children’s Hospital Los Angeles and the Keck School of Medicine of the University of Southern California. He earned his MD degree and interned at Chiang Mai University, Chiang Mai, Thailand. He did his residencies in pediatrics at Chiang Mai University and at Le Bonheur Children’s Medical Center of the University of Tennessee in Memphis where he finished his pediatric endocrine fellowship as well. Dr. Pitukcheewanont’s clinical and research interests have been in pediatric endocrinology especially as it relates to growth and bone health and bone development: the pathogenesis, prevention, and treatment of childhood osteoporosis and type 2 diabetes; and metabolic bone disorders in pediatric patients. He has over 50 publications in peer-reviewed, non-peer-reviewed, book chapters. His recent publications have been concerned with the disparities resulting from the various methods of measuring bone density and pediatric bone disorders.

Publications

A novel SLC12A1 gene mutation associated with hyperparathyroidism, hypercalcemia, nephrogenic diabetes insipidus, and nephrocalcinosis in four patients. Bone. 2017 Apr; 97:121-125. View in: PubMed

A novel SLC12A1 gene mutation associated with hyperparathyroidism, hypercalcemia, nephrogenic diabetes insipidus, and nephrocalcinosis in four patients. Bone. 2017 Jan 14. View in: PubMed

Generalized Arterial Calcification in a Recipient Twin: Discordant Fetal Hemodynamics Result in Differing Phenotypes in Monozygotic Twins with an ABCC6 Mutation. Fetal Diagn Ther. 2017; 41(3):234-236. View in: PubMed

A germline mutation of HRPT2/CDC73 (70 G>T) in an adolescent female with parathyroid carcinoma: first case report and a review of the literature. J Pediatr Endocrinol Metab. 2016 Sep 1; 29(9):1005-12. View in: PubMed

A germline mutation of HRPT2/CDC73 (70 G>T) in an adolescent female with parathyroid carcinoma: first case report and a review of the literature. J Pediatr Endocrinol Metab. 2016 Sep 01; 29(9):1005-12. View in: PubMed

Generalized Arterial Calcification in a Recipient Twin: Discordant Fetal Hemodynamics Result in Differing Phenotypes in Monozygotic Twins with an ABCC6 Mutation. Fetal Diagn Ther. 2016 Mar 17. View in: PubMed

Effects of vitamin D repletion on glycemic control and inflammatory cytokines in adolescents with type 1 diabetes. Pediatr Diabetes. 2016 Feb; 17(1):36-43. View in: PubMed

Progressive osseous heteroplasia, as an isolated entity or overlapping with Albright hereditary osteodystrophy. J Pediatr Endocrinol Metab. 2015 Jul 1; 28(7-8):911-8. View in: PubMed

Progressive osseous heteroplasia, as an isolated entity or overlapping with Albright hereditary osteodystrophy. J Pediatr Endocrinol Metab. 2015 Jul; 28(7-8):911-8. View in: PubMed

Bone health in children and adolescents: risk factors for low bone density. Pediatr Endocrinol Rev. 2013 Mar-Apr; 10(3):318-35. View in: PubMed

Enteral calcium infusion used successfully as treatment for a patient with hereditary vitamin D resistant rickets (HVDRR) without alopecia: a novel mutation. Gene. 2013 Jan 10; 512(2):554-9. View in: PubMed

Identifying an Ectopic Parathyroid Adenoma Using 4DCT in a Pediatric Patient with Persistent Primary Hyperparathyroidism. Case Rep Otolaryngol. 2013; 2013:676039. View in: PubMed

Persistent Müllerian duct syndrome: 8 new cases in Southern California and a review of the literature. Pediatr Endocrinol Rev. 2012 Dec-2013 Jan; 10(2):227-33. View in: PubMed

Sertoli cell tumor and intratubular germ cell neoplasia located in separate gonads in an adolescent patient with complete androgen insensitivity: a case report and review of literature. J Pediatr Endocrinol Metab. 2012; 25(5-6):547-51. View in: PubMed

Mucolipidosis type II (I-cell disease) masquerading as rickets: two case reports and review of literature. J Pediatr Endocrinol Metab. 2012; 25(1-2):191-5. View in: PubMed

Meeting highlights: Lawson Wilkins Pediatric Endocrine Society, Denver, Colorado, USA. April 30 - May 3, 2011. Pediatr Endocrinol Rev. 2011 Dec; 9(2):598-608. View in: PubMed

Scleroderma-like skin changes not involving the hand in a prepubertal male with type I diabetes mellitus: A case report. Dermatoendocrinol. 2011 Oct; 3(4):230-2. View in: PubMed

Bone size and density measurements in prepubertal children with Turner syndrome prior to growth hormone therapy. Osteoporos Int. 2011 Jun; 22(6):1709-15. View in: PubMed

Gorham's disease and diffuse lymphangiomatosis in children and adolescents. Pediatr Blood Cancer. 2011 Apr; 56(4):667-70. View in: PubMed

Physical activity and bone health in children and adolescents. Pediatr Endocrinol Rev. 2010 Mar-Apr; 7(3):275-82. View in: PubMed

Hereditary vitamin D resistant rickets: identification of a novel splice site mutation in the vitamin D receptor gene and successful treatment with oral calcium therapy. Bone. 2009 Oct; 45(4):743-6. View in: PubMed

Lawson Wilkins Pediatric Endocrine Society, Honolulu HI, MAY 2-5, 2008. Pediatr Endocrinol Rev. 2008 Sep; 6(1):42-7. View in: PubMed

Ectopic thymic parathyroid adenoma and vitamin D deficiency rickets: a 5-year-follow-up case report and review of literature. Bone. 2008 Apr; 42(4):819-24. View in: PubMed

2007 Annual Meeting of the Endocrine Society Toronto, Canada (June 2-5, 2007): selected pediatric highlights. Pediatr Endocrinol Rev. 2008 Mar; 5(3):796-803. View in: PubMed

Issues and trends in pediatric growth hormone therapy--an update from the GHMonitor observational registry. Pediatr Endocrinol Rev. 2008 Feb; 5 Suppl 2:702-7. View in: PubMed

Meeting report: the 35th Annual Meeting of the Lawson Wilkins Pediatric Endocrine Society (LWPES) Toronto May 4-6, 2007. Pediatr Endocrinol Rev. 2007 Sep; 5(1):516-25. View in: PubMed

Low cortical bone density measured by computed tomography in children and adolescents with untreated hyperthyroidism. J Pediatr. 2007 May; 150(5):527-30. View in: PubMed

Salt-wasting 21-hydroxylase deficiency congenital adrenal hyperplasia and pyloric stenosis in two Hispanic brothers. J Pediatr. 2006 Aug; 149(2):268-70. View in: PubMed

Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab. 2006 Jun; 91(6):2055-61. View in: PubMed

Extended mutational analyses of FGFR1 in osteoglophonic dysplasia. Am J Med Genet A. 2006 Mar 01; 140(5):537-9. View in: PubMed

Extended mutational analyses of FGFR1 in osteoglophonic dysplasia. Am J Med Genet A. 2006 Mar 1; 140(5):537-9. View in: PubMed

Bone measures in HIV-1 infected children and adolescents: disparity between quantitative computed tomography and dual-energy X-ray absorptiometry measurements. Osteoporos Int. 2005 Nov; 16(11):1393-6. View in: PubMed

Prader-Willi syndrome and mosaic Turner's syndrome. J Pediatr Endocrinol Metab. 2005 Jul; 18(7):711-7. View in: PubMed

Bone densitometry in pediatric populations: discrepancies in the diagnosis of osteoporosis by DXA and CT. J Pediatr. 2005 Jun; 146(6):776-9. View in: PubMed

Bone acquisition in healthy children and adolescents: comparisons of dual-energy x-ray absorptiometry and computed tomography measures. J Clin Endocrinol Metab. 2005 Apr; 90(4):1925-8. View in: PubMed

Quantitative computed tomography measurements of bone mineral density in prepubertal children with congenital hypothyroidism treated with L-thyroxine. J Pediatr Endocrinol Metab. 2004 Jun; 17(6):889-93. View in: PubMed

Characteristics of glycemic control in young children with type 1 diabetes. Pediatr Diabetes. 2002 Dec; 3(4):179-83. View in: PubMed

Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes. J Pediatr. 2002 Nov; 141(5):625-30. View in: PubMed

Bone, muscle, and fat: sex-related differences in prepubertal children. Radiology. 2002 Aug; 224(2):338-44. View in: PubMed

Resumption of growth after methionyl-free human growth hormone therapy in a patient with neutralizing antibodies to methionyl human growth hormone. J Pediatr Endocrinol Metab. 2002 May; 15(5):653-7. View in: PubMed

Powered bySC CTSI